Regeneron Pharmaceuticals is purchasing genetics and biotechnology company 23andMe and has vowed to protect customer data ...

Drug formulation technology company Persist AI has raised $12 million in venture capital funding for its cloud-based robotic ...

In an effort to become more nimble, some companies, like Bayer Pharmaceutical, are getting rid of middle managers.

This Philly-based company is using AI to predict which medical research can lead to profitable drugs and therapies Clarivate ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

Samsung Biologics Co. said it plans to carve its business into a contract drug manufacturer and a holding firm which will ...

President Donald Trump signed an executive order on Monday aimed at lowering prescription drug prices in the U.S. Here's what ...

A new study finds that CivicaScript, a not-for-profit drug manufacturer in the US, can reliably supply essential generic ...

Trump's order seeks to ease regulations to compel more U.S. drug manufacturing. He also plans to assess tariffs on drug ...

The Department of Health and Human Services today announced it has identified specific pricing targets for pharmaceutical ...

Rep. Preston Stinson (R-Edmond) and Sen. Brent Howard (R-Altus) released a joint statement following Governor Kevin Stitt’s ...

Regeneron Pharmaceuticals has promised to comply with 23andMe's existing privacy polices while also using data to fuel drug discovery.